Your Article Summary
See Latest ArticlesComparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma
Current Medical Research and Opinion, 11/21/08
Yan DB et al. - The mean IOP in the first period when all patients were dosed in the evening was assessed 12 h after dosing at 09:00 and it was similar in the two treatment groups. In the a.m.-dosing crossover comparison, the 24-h post-dose IOP was significantly lower on travoprost compared to latanoprost.
Related Articles
Glaucoma and dry eye data from Germany
Ophthalmology Times Europe, 10/27/09
Relevance Score: 93%
Understanding the Importance of IOP Variables in Glaucoma
Survey of Ophthalmology, 10/23/09
Relevance Score: 92%
Characteristics of respondents with glaucoma and dry eye in a national panel survey
Clinical Ophthalmology, 11/13/09
Relevance Score: 91%
Gene-directed therapy in glaucoma may have future clinical applications
Ophthalmology Times Europe, 10/22/09
Relevance Score: 91%
Sequential Glaucoma Implants in Refractory Glaucoma
American Journal of Ophthalmology, 10/20/09
Relevance Score: 91%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate
Expert Opinion in Pharmacotherapy, 12/01/09
Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals
Expert Opinion on Investigational Drugs, 12/01/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Malaria Journal, 12/01/09
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide
Clinical Therapeutics, 12/01/09
Drug-Drug Interaction Between Itraconazole and the Protease Inhibitor Lopinavir/Ritonavir
Annals of Pharmacotherapy, 11/25/09